Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Feb;8(1):74-76.
doi: 10.21037/hbsn.2018.10.10.

Hunting hidden pieces of signaling pathways in hepatocellular carcinoma

Mari Masuda  1
Affiliations
Comment

Hunting hidden pieces of signaling pathways in hepatocellular carcinoma

Mari Masuda. Hepatobiliary Surg Nutr. 2019 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Comment on

  • The protein histidine phosphatase LHPP is a tumour suppressor.
    Hindupur SK, Colombi M, Fuhs SR, Matter MS, Guri Y, Adam K, Cornu M, Piscuoglio S, Ng CKY, Betz C, Liko D, Quagliata L, Moes S, Jenoe P, Terracciano LM, Heim MH, Hunter T, Hall MN. Hindupur SK, et al. Nature. 2018 Mar 29;555(7698):678-682. doi: 10.1038/nature26140. Epub 2018 Mar 21. Nature. 2018. PMID: 29562234 Free PMC article.

References

    1. Llovet JM, Montal R, Sia D, et al. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol 2018;15:599-616. 10.1038/s41571-018-0073-4 - DOI - PMC - PubMed
    1. Hindupur SK, Colombi M, Fuhs SR, et al. The protein histidine phosphatase LHPP is a tumour suppressor. Nature 2018;555:678-82. 10.1038/nature26140 - DOI - PMC - PubMed
    1. Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2016;2:16018. 10.1038/nrdp.2016.18 - DOI - PubMed
    1. Schulze K, Imbeaud S, Letouze E, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 2015;47:505-11. 10.1038/ng.3252 - DOI - PMC - PubMed
    1. Masuda M, Chen WY, Miyanaga A, et al. Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling. Mol Cell Proteomics 2014;13:1429-38. 10.1074/mcp.M113.033845 - DOI - PMC - PubMed